Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
Olivia D. Lara(The University of Texas MD Anderson Cancer Center), Anil K. Sood(The University of Texas MD Anderson Cancer Center)
Cited by 10
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Paraneoplastic Thrombocytosis in Ovarian Cancer
|New England Journal of Medicine|2012|822
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
|New England Journal of Medicine|2008|719
Stress Hormones Regulate Interleukin-6 Expression by Human Ovarian Carcinoma Cells through a Src-dependent Mechanism
|Journal of Biological Chemistry|2007|153
Functional significance of VEGFR‐2 on ovarian cancer cells
|International Journal of Cancer|2008|151